Buchumschlag

New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs)

Introduction: Allergen immunotherapy (AIT) reduces allergic rhinoconjunctivitis (ARC) symptoms, but long-term efficacy requires treatment for 3-5 years. Synthetic peptide immuno-regulatory epitopes, a new class of AIT, are allergen peptides with a shorter, more convenient treatment regimen that coul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Klimek, Ludger (VerfasserIn) , Pfaar, Oliver (VerfasserIn) , Worm, Margitta (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 13 Jun 2016
In: Expert review of clinical immunology
Year: 2016, Jahrgang: 12, Heft: 10, Pages: 1123-1135
ISSN:1744-8409
DOI:10.1080/1744666X.2016.1189825
Online-Zugang:Verlag, Volltext: https://doi.org/10.1080/1744666X.2016.1189825
Volltext
Verfasserangaben:Ludger Klimek, Oliver Pfaar, Margitta Worm
Beschreibung
Zusammenfassung:Introduction: Allergen immunotherapy (AIT) reduces allergic rhinoconjunctivitis (ARC) symptoms, but long-term efficacy requires treatment for 3-5 years. Synthetic peptide immuno-regulatory epitopes, a new class of AIT, are allergen peptides with a shorter, more convenient treatment regimen that could potentially have benefits on adherence and outcomes.Areas covered: Phase 2 trials of therapies derived from cat, house dust mite, grass, and ragweed allergen peptides demonstrated significant reduction in ARC symptoms after short-course treatment; improvement was sustained for 18-24 months posttreatment. We conducted a PubMed literature search for clinical publications using the search terms AIT; allergen peptides; ARC; cat, grass, house dust mite, and ragweed allergy; SCIT; SLIT; and synthetic peptides.Expert commentary: Long-term disease modification is a realistic goal of AIT. The inconvenience of conventional AIT regimens negatively impacts long-term persistence and, thus, efficacy. In comparison, SPIREs have a more convenient treatment regimen that could potentially have benefits on adherence and outcomes.
Beschreibung:Gesehen am 10.07.2019
Beschreibung:Online Resource
ISSN:1744-8409
DOI:10.1080/1744666X.2016.1189825

Ähnliche Einträge